Financials data is unavailable for this security.
View more
Year on year Pharmaust Ltd 's revenues fell -8.78% from 949.58k to 866.18k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 6.21m to a larger loss of 7.67m.
Gross margin | -- |
---|---|
Net profit margin | -1,027.49% |
Operating margin | -1,027.49% |
Return on assets | -103.16% |
---|---|
Return on equity | -126.08% |
Return on investment | -118.57% |
More ▼
Cash flow in AUDView more
In 2024, Pharmaust Ltd increased its cash reserves by 258.99%, or 7.01m. Cash Flow from Financing totalled 13.34m or 1,540.32% of revenues. In addition the company used 5.17m for operations while cash used for investing totalled 1.17m.
Cash flow per share | -0.0197 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.023 |
---|---|
Tangible book value per share | 0.023 |
More ▼
Balance sheet in AUDView more
Current ratio | 12.42 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼